Treatment for severe eosinophilic asthma-consistent effect of anti-interleukin-5 antibodies?
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Washington University School of Medicine, St Louis, MO 63110, USA. Electronic address: castrom@dom.wustl.edu.
Mario
M
Castro
Division of Allergy, Immunology and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine and St Louis Children's Hospital, St Louis, MO, USA.
Leonard B
LB
Bacharier
D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D004802:Eosinophilia / Q000188:drug therapy; D004804:Eosinophils / Q000276:immunology; D006801:Humans; D015848:Interleukin-5 / Q000276:immunology*; D011657:Pulmonary Eosinophilia / Q000188:drug therapy
D018927:Anti-Asthmatic Agents; D061067:Antibodies, Monoclonal, Humanized; D015848:Interleukin-5